Singapore · Biotechnology startup
Singapore · SCG Cell Therapy
SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.
Funding reportedLast round: Series C
Follow SCG Cell Therapy and see its new rounds in your feed.Start following
What company datasets say SCG Cell Therapy raised
Funding, as reported
Reported in all8.1Min the source's currency
Rounds1
Last roundSeries C
Last round dateApr 2023
Investors listed1
Biotechnology in Singapore
Startups like it
Is this your company?
Add your raise, your deck and your story, and put SCG Cell Therapy in front of investors. Or tell us what we have wrong.